BioPrax™
Acute Periprosthetic Joint Infection (PJI)
Key Facts
About Garwood Medical Devices
Garwood Medical Devices is an early-stage, pre-revenue medical device company tackling the significant clinical and economic challenge of periprosthetic joint infections (PJIs). The company's proprietary platform technology, developed in partnership with the University at Buffalo, uses electrochemical methods to disrupt bacterial biofilms on implants, aiming to improve the success rate of early intervention treatments. With FDA Breakthrough Device designation for its BioPrax™ system, Garwood is positioned to address a high-cost, high-mortality unmet need in orthopedics, though it faces the typical risks of clinical development, regulatory hurdles, and market adoption for a novel therapeutic approach.
View full company profile